PI3K-alpha drugs for Breast Cancer
2 tracked PI3K-alpha drugs in the Breast Cancer race. The class explanation lives on the PI3K-alpha page; the full indication pipeline across every mechanism is on the Breast Cancer page.
2 approved / phase 4
Head-to-head evidence: Alpelisib (BYL719) vs Inavolisib